May 1, 2018 / 8:44 PM / 7 months ago

Generic drugmaker urges Fed Circ to rehear Google patent case, fearing 'vexatious lawsuits'

An Indian generic drug company on Monday urged a federal appeals court to reconsider a recent decision that revived a patent infringement case against Google LLC, saying the ruling could spur “vexatious lawsuits” by makers of brand-name pharmaceutical products.

Dr Reddy’s Laboratories Ltd asked the U.S. Court of Appeals for the Federal Circuit to rehear en banc its March 12 decision that a lawsuit brought against Google by licensing company SimpleAir Inc was not barred by the doctrine of claim preclusion.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below